vs
Amarin Corp plc(AMRN)与Repay Holdings Corp(RPAY)财务数据对比。点击上方公司名可切换其他公司
Repay Holdings Corp的季度营收约是Amarin Corp plc的1.7倍($78.6M vs $45.1M),Amarin Corp plc净利率更高(-23.3% vs -178.3%,领先155.0%),Amarin Corp plc同比增速更快(7.0% vs 0.4%),过去两年Repay Holdings Corp的营收复合增速更高(-1.3% vs -18.3%)
Amarin是一家1993年成立的爱裔美籍生物制药企业,总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物,已推出处方级Omega-3脂肪酸药物Vascepa(AMR-101)。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商,为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案,涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具,助力客户简化交易流程、提升运营效率。
AMRN vs RPAY — 直观对比
营收规模更大
RPAY
是对方的1.7倍
$45.1M
营收增速更快
AMRN
高出6.6%
0.4%
净利率更高
AMRN
高出155.0%
-178.3%
两年增速更快
RPAY
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $45.1M | $78.6M |
| 净利润 | $-10.5M | $-140.1M |
| 毛利率 | — | 74.2% |
| 营业利润率 | 35.5% | -182.2% |
| 净利率 | -23.3% | -178.3% |
| 营收同比 | 7.0% | 0.4% |
| 净利润同比 | 33.0% | -3304.1% |
| 每股收益(稀释后) | — | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AMRN
RPAY
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $78.6M | ||
| Q3 25 | $49.7M | $77.7M | ||
| Q2 25 | $72.7M | $75.6M | ||
| Q1 25 | $42.0M | $77.3M | ||
| Q4 24 | $62.3M | $78.3M | ||
| Q3 24 | $42.3M | $79.1M | ||
| Q2 24 | $67.5M | $74.9M |
净利润
AMRN
RPAY
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $-140.1M | ||
| Q3 25 | $-7.7M | $-6.4M | ||
| Q2 25 | $-14.1M | $-102.3M | ||
| Q1 25 | $-15.7M | $-7.9M | ||
| Q4 24 | $-48.6M | $-4.1M | ||
| Q3 24 | $-25.1M | $3.2M | ||
| Q2 24 | $1.5M | $-4.1M |
毛利率
AMRN
RPAY
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | 74.2% | ||
| Q3 25 | 44.7% | 74.4% | ||
| Q2 25 | 69.2% | 75.7% | ||
| Q1 25 | 59.8% | 75.9% | ||
| Q4 24 | -15.4% | 76.3% | ||
| Q3 24 | 38.5% | 77.8% | ||
| Q2 24 | 63.4% | 78.2% |
营业利润率
AMRN
RPAY
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | -182.2% | ||
| Q3 25 | -22.4% | -3.9% | ||
| Q2 25 | -22.0% | -138.7% | ||
| Q1 25 | -39.9% | -4.7% | ||
| Q4 24 | -84.3% | -1.5% | ||
| Q3 24 | -59.5% | -0.9% | ||
| Q2 24 | -0.8% | -4.6% |
净利率
AMRN
RPAY
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | -178.3% | ||
| Q3 25 | -15.6% | -8.3% | ||
| Q2 25 | -19.4% | -135.2% | ||
| Q1 25 | -37.4% | -10.3% | ||
| Q4 24 | -78.0% | -5.3% | ||
| Q3 24 | -59.4% | 4.1% | ||
| Q2 24 | 2.3% | -5.4% |
每股收益(稀释后)
AMRN
RPAY
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $-1.68 | ||
| Q3 25 | $-0.02 | $-0.08 | ||
| Q2 25 | $-0.03 | $-1.15 | ||
| Q1 25 | $-0.04 | $-0.09 | ||
| Q4 24 | $-0.12 | $-0.04 | ||
| Q3 24 | $-0.06 | $0.03 | ||
| Q2 24 | $0.00 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $115.7M |
| 总债务越低越好 | — | $280.1M |
| 股东权益账面价值 | — | $484.4M |
| 总资产 | $645.8M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.58× |
8季度趋势,按日历期对齐
现金及短期投资
AMRN
RPAY
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $115.7M | ||
| Q3 25 | $286.6M | $95.7M | ||
| Q2 25 | $298.7M | $162.6M | ||
| Q1 25 | $281.8M | $165.5M | ||
| Q4 24 | $294.2M | $189.5M | ||
| Q3 24 | $305.7M | $168.7M | ||
| Q2 24 | $306.7M | $147.1M |
总债务
AMRN
RPAY
| Q1 26 | — | — | ||
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M |
股东权益
AMRN
RPAY
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $484.4M | ||
| Q3 25 | $458.9M | $616.9M | ||
| Q2 25 | $464.9M | $633.7M | ||
| Q1 25 | $473.7M | $755.7M | ||
| Q4 24 | $486.2M | $761.3M | ||
| Q3 24 | $531.4M | $754.7M | ||
| Q2 24 | $551.9M | $815.4M |
总资产
AMRN
RPAY
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $1.2B | ||
| Q3 25 | $659.8M | $1.3B | ||
| Q2 25 | $670.1M | $1.4B | ||
| Q1 25 | $655.7M | $1.5B | ||
| Q4 24 | $685.3M | $1.6B | ||
| Q3 24 | $750.6M | $1.6B | ||
| Q2 24 | $799.9M | $1.5B |
负债/权益比
AMRN
RPAY
| Q1 26 | — | — | ||
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $23.3M |
| 自由现金流经营现金流 - 资本支出 | — | $23.2M |
| 自由现金流率自由现金流/营收 | — | 29.6% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $90.7M |
8季度趋势,按日历期对齐
经营现金流
AMRN
RPAY
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $23.3M | ||
| Q3 25 | $-12.7M | $32.2M | ||
| Q2 25 | $16.6M | $33.1M | ||
| Q1 25 | $-12.5M | $2.5M | ||
| Q4 24 | $-13.3M | $34.3M | ||
| Q3 24 | $-2.4M | $60.1M | ||
| Q2 24 | $-2.7M | $31.0M |
自由现金流
AMRN
RPAY
| Q1 26 | — | — | ||
| Q4 25 | — | $23.2M | ||
| Q3 25 | — | $32.1M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $2.4M | ||
| Q4 24 | — | $34.0M | ||
| Q3 24 | — | $59.8M | ||
| Q2 24 | — | $30.5M |
自由现金流率
AMRN
RPAY
| Q1 26 | — | — | ||
| Q4 25 | — | 29.6% | ||
| Q3 25 | — | 41.3% | ||
| Q2 25 | — | 43.6% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | 43.5% | ||
| Q3 24 | — | 75.6% | ||
| Q2 24 | — | 40.7% |
资本支出强度
AMRN
RPAY
| Q1 26 | — | — | ||
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.6% |
现金转化率
AMRN
RPAY
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 18.52× | ||
| Q2 24 | -1.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |